Hlavní stranaMezinárodní biotech událostiWorld Congress of Immunodiseases and Therapy

World Congress of Immunodiseases and Therapy

 

Beijing, China (May 15-17, 2010)

Tentative Program

Symposium 1: Research Frontiers on Immune DiseasesSession 1-1: The Immunity Diseases Molecular MechanismsSession 1-2: Immunopathology, Etiology and Pathogenic Role of ComplementSession 1-3: Genetics of Immune and Autoimmunity DiseasesSession 1-4: Cell and Molecular Biology of AutoimmunitySession 1-5: Tumor ImmunologySession 1-6: Innate to Acquired (Adaptive) Immunity and DiseasesSession 1-7: Toll-like Receptors and Pattern Recognition ReceptorsSession 1-8: Immune Signal Transduction and Cross-talkSession 1-9: Immune Regulations- Regulatory T Cells and T Cell SubsetsSession 1-10: Dendritic Cells, Macrophages and other Innate Immune CellsSession 1-11: Human Immunology and ImmunodeficienciesSession 1-12: Hypersensitivity, Antigen Processing and PresentationSession 1-13: Immunological Inflammations and Vascular InjurySession 1-14: Neuroimmunology, Neuroendocrine Immunology and PsychoneuroimmunologySession 1-15: Natural Killer Cells, Apoptosis & ImmunitySession 1-16: Infection and Immunity, Epidemiology of Immune DiseasesSession 1-17: Prophylaxis and InterventionSession 1-18: Mucosal ImmunologySession 1-19: Immunochemistry & ImmunobiologySession 1-20: Immune Tolerance in Autoimmune Disease

Symposium 2: Leading Technologies in ImmunologySession 2-1: System Biology and Computational ImmunologySession 2-2: Hybridoma TechnologySession 2-3: Sensitivity and Accuracy in Imaging ImmunitySession 2-4: Immunogenomics & ImmunoproteomicsSession 2-5: Biochips, Microarray Based TechnologySession 2-6: New Immune Intervention TechnologiesSession 2-7: Small RNAs in Development and Immune DiseasesSession 2-8: Nucleic Acids in Innate ImmunitySession 2-9: The Stem Cells and Implications in Immune DiseasesSession 2-10: The SCID Mouse as Model of Immune Diseases

Symposium 3: Immune Disease Drug Discovery & DevelopmentSession 3-1: Molecular Targets and Biomarkers of ImmunotherapeuticsSession 3-2: Computer Aided Drug Design & Medicinal ChemistrySession 3-3: ImmunopharmacologySession 3-4: Immunosuppression and Immunotherapy DevelopmentSession 3-5: Cytokines, Chemokine and Cell Adhesion Molecules and Drug DiscoverySession 3-6: Gene and Cell TherapySession 3-7: Monoclonal Antibody and Antibody EngineeringSession 3-8: Innate Immunity and Novel VaccinesSession 3-9: Novel Drug Delivery Systems of ImmunotherapeuticsSession 3-10: Traditional Medicines for Immune and Inflammatory Diseases

Symposium 4: Medical Research and Immune DiseasesSession 4-1: Immunity and Emerging Infectious DiseaseSession 4-2: Hormones and Immune Response Mediated DiseasesSession 4-3: Allergy, Asthma & Clinical ImmunologySession 4-4: Autoimmunity Mediated DiseasesSession 4-5: Lymphocyte Development and Functions in Immune DiseasesSession 4-6: Immunosenescence and Clinical ApplicationsSession 4-7: Immunity and AgingSession 4-8: Reproductive ImmunologySession 4-9: Neonatal and Maternal ImmunizationSession 4-10: Translational Immunology

Symposium 5: Diagnostics & Immunotherapy of Major DiseasesSession 5-1: Biomarkers for Molecular Diagnostics of Immune DiseasesSession 5-2: Insulin-Dependent Diabetes MellitusSession 5-3: Allergy, Asthma and Rheumatoid ArthritisSession 5-4: Inflammatory Bowel Disease and Ocular InflammationSession 5-5: Vasculitis and Cardiovascular DiseasesSession 5-6: Lung Inflammation and FibrosisSession 5-7: Autoimmune Hepatitis and Chronic Liver DiseasesSession 5-8: Multiple Sclerosis, Scleroderma, Myasthenia Gravis, and Neuromuscular DiseasesSession 5-9: Systemic Lupus Erythematosus and and Other Connective Tissue DiseasesSession 5-10: Psoriasis, Allergic Skin Diseases and ImmunodermatologySession 5-11: Immunotherapy on Reemerging TB and MalariaSession 5-12: Immunological Renal Diseases, and Organ Transplant RejectionSession 5-13: Major Cancers- Breast CancerSession 5-14: Major Cancers-Head, Brain and Neck CancersSession 5-15: Major Cancers- Cervical and Ovarian CancerSession 5-16: Major Cancers- Pancreatic , Prostate, and Renal CancerSession 5-17: Major Cancers- Leukemia, Lymphoma & MelanomaSession 5-18: Major Cancers- Lung CancerSession 5-19: Major Infectious Diseases- HIV/AIDS and Other Viral InfectionsSession 5-20: Major Infectious Diseases-Resistant Bacterial Infections

Symposium 6: Benchmark Analysis and Case StudiesSession 6-1: Anticancer DrugsSession 6-2: Anti-inflammatory DrugsSession 6-3: Anti-allergy and Asthma DrugsSession 6-4: Anti-Infectious DrugsSession 6-5: Anti-Autoimmune Drugs

Více: http://www.bitlifesciences.com/WCIT2010/default.asp


OPPI, MPO, EU



Váš názor

Vyhledáváte partnery ke spolupráci na projektu?

NE
NE

ANO
ANO

ANO, ale jen tuzemské
ANO, ale jen tuzemské